Universitätsklinikum Köln

Hospital


Location: Köln (Cologne), Germany (DE) DE

ISNI: 000000008852305X

ROR: https://ror.org/05mxhda18

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Frühgeborene an der Grenze der Lebensfähigkeit (Entwicklungsstufe S2k, AWMF-Leitlinien-Register Nr024/019, Juni 2020) (2020) Bührer C, Felderhoff-Müser U, Gembruch U, Hecher K, Kainer F, Kehl S, Kidszun A, et al. Journal article Evaluation of pregnancies after allogeneic stem cell transplantation during the last 15years in Germany (2020) Sockel K, Frank S, Neu A, Ditschkowski M, Hilgendorf I, Goeckenjan M, Stoelzel F, et al. Conference contribution Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer (2020) Hecht M, Hahn D, Wolber P, Hautmann MG, Reichert D, Weniger S, Belka C, et al. Journal article Artificial Intelligence and Its Effect on Dermatologists' Accuracy in Dermoscopic Melanoma Image Classification: Web-Based Survey Study (2020) Maron RC, Utikal JS, Hekler A, Hauschild A, Sattler E, Sondermann W, Haferkamp S, et al. Journal article Dynamic spinal posture and pelvic position analysis using a rasterstereographic device (2020) Michalik R, Hamm J, Quack V, Eschweiler J, Gatz M, Betsch M Journal article Survival analysis of the randomized phase III GeparOcto trial comparing neoadjuvant chemotherapy (NACT) of iddEPC versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triplenegative breast cancer, TNBC) (PM(Cb)) for patients (pts) with highrisk early breast cancer (BC) (2020) Schneeweiss A, Moebus V, Tesch H, Klare P, Denkert C, Kast K, Hanusch C, et al. Conference contribution GeparX: Denosumab (Dmab) as add-on to different regimen of nab-paclitaxel (nP)-anthracycline based neoadjuvant chemotherapy (NACT) in early breast cancer (BC): Subgroup analyses by RANK expression and HR status (2020) Link T, Blohmer JU, Just M, Untch M, Stoetzer O, Fasching P, Schneeweiss A, et al. Conference contribution Germline mutation status and therapy response in patients with homologous recombination deficient, HER2-negative early breast cancer: Results of the GeparOLA study (NCT02789332) (2020) Hauke J, Ernst C, Fasching P, Jackisch C, Seither F, Klare P, Rhiem KE, et al. Conference contribution Prospective Multicenter BAL Study: Focus real-time PCR (2020) Springer J, Rickerts V, Teschner D, Kessel J, Liebregts T, Cornely A, Schwartz S, et al. Conference contribution Study: P. jirovecii Pathogen Quantification and Resistance Testing in Patients with Pneumocystis pneumonia (PCP) and Pneumocystis Colonization (2020) Riebold D, Stocker H, Koehler P, Bauer TT, Kroegel C, Harrer T, Slevogt H Conference contribution